The Asia Pacific Serum Separation Gel Market would witness market growth of 7.4% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Serum Separation Gel Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,058.1 million by 2031. The Japan market is registering a CAGR of 6.8% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 8.1% during (2024 - 2031).
Blood banks perform rigorous screening tests on donated blood to detect infectious diseases, bloodborne pathogens, and other transfusion-transmissible infections. Serum separation gel facilitates the collection of serum samples used in serological screening tests, nucleic acid amplification assays, and other diagnostic procedures performed in blood banks. The expansion of blood screening programs drives the demand for serum separation gel in blood banking and transfusion medicine.
Additionally, there is an increasing emphasis on quality assurance and regulatory compliance in diagnostic laboratories and healthcare settings. Manufacturers of serum separation gel are prioritizing the development of products that meet stringent quality standards and regulatory requirements. This includes ensuring serum separation products' safety, purity, and performance through comprehensive testing, validation studies, and adherence to relevant regulatory guidelines.
The Asia Pacific region is witnessing rapid growth in its pharmaceutical industry, driven by increasing healthcare expenditure, rising demand for pharmaceutical products, and expanding access to healthcare services. The biotechnology and life sciences sectors are experiencing rapid growth in Asia Pacific, fuelled by investments in research and development, government initiatives, and technological advancements. Therefore, due to the above-mentioned factors, the serum separation gel market will grow significantly in this region.
Based on Product Type, the market is segmented into Serum Separation Gel Integrated with Tube, and Serum Separation Gel Integrated without Tube. Based on End User, the market is segmented into Blood Bank, Hospital, Pharmaceutical & Companies, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The China market dominated the Asia Pacific Serum Separation Gel Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,058.1 million by 2031. The Japan market is registering a CAGR of 6.8% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 8.1% during (2024 - 2031).
Blood banks perform rigorous screening tests on donated blood to detect infectious diseases, bloodborne pathogens, and other transfusion-transmissible infections. Serum separation gel facilitates the collection of serum samples used in serological screening tests, nucleic acid amplification assays, and other diagnostic procedures performed in blood banks. The expansion of blood screening programs drives the demand for serum separation gel in blood banking and transfusion medicine.
Additionally, there is an increasing emphasis on quality assurance and regulatory compliance in diagnostic laboratories and healthcare settings. Manufacturers of serum separation gel are prioritizing the development of products that meet stringent quality standards and regulatory requirements. This includes ensuring serum separation products' safety, purity, and performance through comprehensive testing, validation studies, and adherence to relevant regulatory guidelines.
The Asia Pacific region is witnessing rapid growth in its pharmaceutical industry, driven by increasing healthcare expenditure, rising demand for pharmaceutical products, and expanding access to healthcare services. The biotechnology and life sciences sectors are experiencing rapid growth in Asia Pacific, fuelled by investments in research and development, government initiatives, and technological advancements. Therefore, due to the above-mentioned factors, the serum separation gel market will grow significantly in this region.
Based on Product Type, the market is segmented into Serum Separation Gel Integrated with Tube, and Serum Separation Gel Integrated without Tube. Based on End User, the market is segmented into Blood Bank, Hospital, Pharmaceutical & Companies, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Becton, Dickinson, and Company
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Sysmex Corporation
- Charles River Laboratories International, Inc.
- QuidelOrtho Corporation
Market Report Segmentation
By Product Type- Serum Separation Gel Integrated with Tube
- Serum Separation Gel Integrated without Tube
- Blood Bank
- Hospital
- Pharmaceutical & Companies
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Serum Separation Gel Market by Product Type
Chapter 5. Asia Pacific Serum Separation Gel Market by End User
Chapter 6. Asia Pacific Serum Separation Gel Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Becton, Dickinson, and Company
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Sysmex Corporation
- Charles River Laboratories International, Inc.
- QuidelOrtho Corporation
Methodology
LOADING...
